Arbelic (telavancin)

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 85 (Table of Contents)

Published: 7 Jul-2007

DOI: 10.3833/pdr.v2007.i85.324     ISSN: 1756-7874

Section: Deal Trackers



Telavancin, originally compound 21, was discovered by Theravance using the company’s multivalent drug design technique in a research programme that aimed to fi nd new antibiotics for serious infections caused by Staphylococcus aureus (including multidrug resistant strains) and other Gram-positive pathogens...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details